MiraKind is a nonprofit research organization founded by Dr. Joanne Weidhaas, following her discovery of the KRAS-variant, an inherited genetic mutation associated with an increased risk of cancer. Every year scientists like Dr. Weidhaas discover hundreds of novel genetic markers that could benefit millions of patients.  Unfortunately, very few of these discoveries make it beyond the research laboratory for validation.  Dr. Weidhaas founded MiraKind to change this by breaking down the barriers between doctors, scientists, and patients to validate these novel findings, and to ask the questions that will lead to actionable strategies to reduce cancer risk and suffering.  MiraKind's research is patient-centered from start to finish, with the ultimate goal of empowering patients so that, together with their doctors, they can make the best decisions for their health and lifestyle.  Our research is guided by one question: How can we enhance health and longevity for all individuals?

MiraKind

Org chart

Teams

Offices